You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

β-CELLS,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen Children's Hospital
Feb 24, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen University General Hospital
May 8, 2023

ß Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

Active, not recruiting
  • β Thalassemia Major
  • γ-globin reactivated autologous hematopoietic stem cells
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories Inc.
Oct 9, 2022

Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)

Not yet recruiting
  • Thalassemia, Beta
  • Thalassemia Major
  • VGB-Ex01
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Sep 11, 2023

Beta-Thalassemia Trial in Nanning (CS-101)

Recruiting
  • Beta-Thalassemia
  • CS-101
  • Nanning, China
    The First Affiliated Hospital of Guangxi Medical University
Sep 9, 2023

Transfusion Dependent Beta-Thalassemia Trial in Nanning (GMCN-508B (LentiRed))

Recruiting
  • Transfusion Dependent Beta-Thalassemia
  • GMCN-508B (LentiRed)
  • Nanning, Guangxi, China
    The affiliated hospital of guangxi medical university
Feb 28, 2023

Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

Not yet recruiting
  • Thalassemia Major
  • γ-globin reactivated autologous hematopoietic stem cells
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories Inc
Jul 1, 2022

Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

Not yet recruiting
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • (no location specified)
Jul 26, 2022

Transfusion Dependent Beta-Thalassaemia Trial in Guangzhou, Shenzhen, Tianjin (ET-01)

Active, not recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Guangzhou, Guangdong, China
  • +3 more
May 9, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

Not yet recruiting
  • Graft Vs Host Disease
  • +5 more
  • CliniMACS® device
  • (no location specified)
Jul 20, 2023

IBD, Ulcerative Colitis, Crohn Disease Trial in Stanford (Vitamin D)

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • Vitamin D
  • Stanford, California
    Stanford University School of Medicine
Oct 24, 2022

Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using

Recruiting
  • Relapsed Pediatric ALL
  • +2 more
  • In Vitro T cells depletion using CliniMCAS system
  • Shanghai, China
    Shanghai Children's Medical Center
Sep 28, 2022

Venous Leg Ulcer Trial in Linköping (XSTEM-VLU, Vehicle)

Recruiting
  • Venous Leg Ulcer
  • XSTEM-VLU
  • Vehicle
  • Linköping, Sweden
    Burn Centre, Linköping University Hospital
Jan 24, 2023

Osteoarthritis, Knee Trial in Camberwell (XSTEM-OA)

Recruiting
  • Osteoarthritis, Knee
  • XSTEM-OA
  • Camberwell, Victoria, Australia
    Emeritus Research
Jul 12, 2022

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Beta-Thalassemia Trial in Worldwide (LentiGlobin BB305 Drug Product)

Active, not recruiting
  • Beta-Thalassemia
  • LentiGlobin BB305 Drug Product
  • Oakland, California
  • +8 more
Feb 4, 2022

Hematologic Diseases Trial in Kunming (BD211 Drug Product)

Enrolling by invitation
  • Hematologic Diseases
  • BD211 Drug Product
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Aug 14, 2021

ß-Thalassemia Major Trial in Shenzhen (ß-globin restored autologous HSC)

Not yet recruiting
  • β-Thalassemia Major
  • β-globin restored autologous HSC
  • Shenzhen, Guangdong, China
    Beijing Genomics Institute At Shenzhen
Oct 13, 2020

Type 2 Diabetes Trial in Guangzhou (CSII followed by Lina+MET, CSII followed by Lina, CSII followed by MET)

Recruiting
  • Type 2 Diabetes Mellitus
  • CSII followed by Lina+MET
  • +3 more
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Apr 28, 2021

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

RRMM Trial in Lishui, Wenzhou (CAR-T therapy in Relapsed/Refractory multiple myeloma)

Unknown status
  • RRMM
  • CAR-T therapy in Relapsed/Refractory multiple myeloma
  • Lishui, Zhejiang, China
  • +2 more
Nov 16, 2020

Squamous Cell Carcinoma of the Oral Cavity Trial in Taipei (ß-glucan)

Unknown status
  • Squamous Cell Carcinoma of the Oral Cavity
  • β-glucan
  • Taipei, Taiwan
    National Taiwan University Hospital
May 10, 2020